详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

DMRT1 could serve as a prognostic biomarker for bladder cancer patients

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China. [2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China [3]Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China

出处：

DOI：

ISSN：

摘要：

Dear Editor, Bladder cancer (BLCA) is reported as one of the most common genitourinary malignancies which usually occurs in elderly people.1 There is a critical clinical need for biomarkers that can precisely predict patient outcomes and responses to treatments in the current era of precision oncology. In our research, we initially investigate the impact of DMRT1 on BLCA patients using bioinformatic analysis, using methodologies detailed in our prior study.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 3 区医学

小类 | 3 区外科

最新[2023]版：

大类 | 3 区医学

小类 | 3 区外科

第一作者：

第一作者机构： [1]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.

共同第一作者：

通讯作者：

通讯机构： [2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China [3]Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China

推荐引用方式(GB/T 7714)：

APA：

MLA：